The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia
The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia
This randomized, double-blinded, placebo-controlled, crossover clinical trial aims to
 investigate the effect of VGH-BPH1, a scientific Chinese medicine powder prescription, on
 patients with benign prostatic hyperplasia.
Benign prostatic hyperplasia (BPH) is an enlargement of the prostate gland due to progressive
 hyperplasia of the stromal and glandular cells.

 The aim of this study is to evaluate the efficacy of traditional Chinese medicine (VGH-BPH1)
 in treating patients with BPH, by using the experimental BPH-1 powder, including Ji Sheng
 Shen Qi Wan and Sangpiaoxiao powder as the main prescription, and adding Wuyao, Yizhiren,
 Danshen, Yinyanghuo, Fupenzi, Huangbo and Zhimu as auxiliary ingredients, to form a 5gm per
 pack. This study is designed as a double-blinded randomized placebo-controlled cross-over
 trial to provide experimental evidence and feasibility of traditional Chinese medicine
 VGH-BPH1 in the treatment of BPH, and to analyze the syndrome pattern of Chinese medicinal
 prescriptions for subgroups of BPH.
Inclusion Criteria:

 -  Patients who have been diagnosed with benign prostatic hyperplasia by a urologist

 -  Have been treated with conventional first-line western medicine for more than three
 months

 -  Patients with moderate to severe benign prostatic hyperplasia (IPSS score >12 points)

 -  Participate voluntarily in the study

 Exclusion Criteria:

 -  At the same time, use other Chinese herbal medicines or alternative medicine
 (including drugs and acupuncture) for more than one month.

 -  Syphilis, gonorrhea and other sexually transmitted diseases or urinary tract
 infections

 -  Urinary tract stones, prostate cancer, bladder cancer or acute and chronic renal
 failure

 -  Congenital abnormalities such as bladder neck fibrosis, interstitial cystitis or
 urethral stricture

 -  A history of genital trauma or surgery affecting the muscle or nervous system

 -  Patients with upper urinary tract obstruction, renal edema, etc. affecting renal
 function

 -  Unable to sign a consent form or unable to communicate with researchers